US2012211736A1PendingUtilityA1
Compound for organic photoelectric device and organic photoelectric device including the same
Est. expiryNov 3, 2029(~3.3 yrs left)· nominal 20-yr term from priority
Inventors:Hyung Sun KimEun-Sun YuSoo-Hyun MinHo-Jae LeeEui-Su KangMi-Young ChaeYoung-Hoon KimJa-Hyun Kim
H10K 50/15H10K 50/17H10K 50/16H10K 50/171H10K 85/631C09K 2211/1018C09K 11/06C09B 57/008C09B 57/00C09K 2211/1048C09K 2211/1059Y02E10/549H05B 33/14C09K 2211/1044C09K 2211/1029C09K 2211/1011C09K 2211/1007H10K 85/656H10K 85/654H10K 85/6572H10K 50/11H10K 85/6576H10K 85/636H10K 85/6574H10K 85/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A compound for an organic photoelectric device, the compound being represented by the following Chemical Formula (“CF”) 1:
Claims
exact text as granted — not AI-modified1 . A compound for an organic photoelectric device, the compound being represented by the following Chemical Formula (“CF”) 1:
wherein, in CF 1,
Ar1 and Ar2 are each independently selected from the group of a substituted or unsubstituted C6 to C30 aryl group and a substituted or unsubstituted C2 to C30 heteroaryl group,
Ar3 and Ar4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group, and
R1 to R4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group.
2 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by the following CF 3:
wherein, in CF 3,
Ar1 and Ar2 are each independently selected from the group of a substituted or unsubstituted C6 to C30 aryl group and a substituted or unsubstituted C2 to C30 heteroaryl group,
Ar3 and Ar4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group, and
R1 to R4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group.
3 . The compound as claimed in claim 2 , wherein the compound represented by CF 3 is represented by the following CF 5:
wherein, in CF 5,
Ar1 and Ar5 are each independently selected from the group of a substituted or unsubstituted C6 to C30 aryl group and a substituted or unsubstituted C2 to C30 heteroaryl group,
Ar3, Ar4 and Ar6 are each independently selected from the group of hydrogen, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group, and
R1 to R6 are each independently selected from the group of hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group.
4 . The compound as claimed in claim 3 , wherein:
Ar5 is a C6 to C12 aryl group, and Ar2 is a C10 to C20 fused polycyclic group.
5 . The compound as claimed in claim 3 , wherein:
Ar5 is a C6 to C12 aryl group, and Ar2 is selected from the group of a C6 to C30 substituted or unsubstituted an arylamine group, C6 to C30 substituted or unsubstituted aminoaryl group, a substituted or unsubstituted carbazole group, a substituted or unsubstituted pyridine group, a substituted or unsubstituted pyrimidine group, and a substituted or unsubstituted triazine group.
6 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by the following CF 2:
wherein, in CF 2,
Ar1 and Ar2 are each independently selected from the group of a substituted or unsubstituted C6 to C30 aryl group and a substituted or unsubstituted C2 to C30 heteroaryl group,
Ar3 and Ar4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group, and
R1 to R4 are each independently selected from the group of hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group.
7 . The compound as claimed in claim 6 , wherein the compound represented by CF 2 is represented by the following CF 4:
wherein, in CF 4,
Ar1 and Ar5 are each independently selected from the group of a substituted or unsubstituted C6 to C30 aryl group and a substituted or unsubstituted C2 to C30 heteroaryl group,
Ar3, Ar4 and Ar6 are each independently selected from the group of hydrogen, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group, and
R1 to R6 are each independently selected from the group of hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, and a substituted or unsubstituted C2 to C30 heteroaryl group.
8 . The compound as claimed in claim 7 , wherein:
Ar5 is a C6 to C12 aryl group, and Ar2 is a C10 to C20 fused polycyclic group.
9 . The compound as claimed in claim 7 , wherein:
Ar5 is a C6 to C12 aryl group, and Ar2 is selected from the group of a C6 to C30 substituted or unsubstituted an arylamine group, C6 to C30 substituted or unsubstituted aminoaryl group, a substituted or unsubstituted carbazole group, a substituted or unsubstituted pyridine group, a substituted or unsubstituted pyrimidine group, and a substituted or unsubstituted triazine group.
10 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by one or more of the following CF 6 to 37:
11 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by one or more of the following CF 38 and 42 to 72.
12 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by one or more of the following CF 73 to 83.
13 . The compound as claimed in claim 1 , wherein the compound represented by CF 1 is represented by one or more of the following CF N-3 to N-54, A-2 to A-26, B-3 to B-22, and C-1 to C-18:
14 . An organic photoelectric device, comprising:
an anode, a cathode, and at least one organic thin layer, the at least one organic thin layer being disposed between the anode and cathode, and including the compound as claimed in claim 1 .
15 . The organic photoelectric device as claimed in claim 14 , wherein the organic thin layer is selected from the group of an emission layer, a hole transport layer (HTL), a hole injection layer (HIL), an electron transport layer (ETL), an electron injection layer (EIL), a hole blocking layer, and a combination thereof.
16 . The organic photoelectric device as claimed in claim 14 , wherein the compound is included in an electron transport layer (ETL) or an electron injection layer (EIL).
17 . The organic photoelectric device as claimed in claim 14 , wherein the compound is included in an emission layer.
18 . The organic photoelectric device as claimed in claim 14 , wherein the compound is used as a phosphorescent or fluorescent host material in an emission layer.
19 . The organic photoelectric device as claimed in claim 14 , wherein the compound is used as a fluorescent blue dopant material in an emission layer.
20 . A display device comprising an organic photoelectric device according to claim 14 .Join the waitlist — get patent alerts
Track US2012211736A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.